Vimentin: Regulation and pathogenesis.

Biochimie

Sorbonne Université, Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Inserm ERL U1164, Biological Adaptation and Ageing, 75005, Paris, France. Electronic address:

Published: June 2022

Vimentin, an abundant cytoplasmic intermediate filament protein, is recognized for its important role in stabilizing intracellular structure. Vimentin has been recognized for its mechanical role in cell plasticity and stress absorbers. Additionally, the functions of vimentin, similar to all other cytoplasmic intermediate filaments, are correlated to its ability to interact with cellular components responsible for signaling as well as kinases, therefore exerting control on gene regulatory networks. Moreover, several studies reveal a novel form of vimentin present at the surface of the plasma membrane or released in the extracellular environment in different physiological and pathological conditions. Based on data pertaining to vimentin's location outside of the cell, novel functions have emerged. The vimentin promoter is complex and appears to be controlled by a combination of positive and negative regulatory elements. In this review, we first present the involvement of these regulatory elements as well as epigenetic regulation of vimentin in different physiological and pathological contexts, including cell growth, cell differentiation, cancer, epithelial to mesenchymal transition and viral infection. Furthermore, this review also analyzes the secretion of vimentin, its presence at the cell surface, the role of extracellular vimentin as a specific marker, its function as a receptor for the von Willebrand factor as well as the entry of viruses, requirements for pathogen invasion, transcellular migration, and the immune response. Finally, a discussion is featured regarding the delocalization of vimentin that may contribute to diseases and disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biochi.2022.02.003DOI Listing

Publication Analysis

Top Keywords

vimentin
10
cytoplasmic intermediate
8
physiological pathological
8
regulatory elements
8
cell
5
vimentin regulation
4
regulation pathogenesis
4
pathogenesis vimentin
4
vimentin abundant
4
abundant cytoplasmic
4

Similar Publications

Sophaline B inhibits non-small cell lung cancer by activating NLRP3/caspase-1/GSDMD-dependent pyroptosis and PI3K/AKT/mTOR-mediated autophagy.

Nat Prod Res

January 2025

Institute of Biopharmaceutical and Health Engineering, State Key Laboratory of Chemical Oncogenomics, Shenzhen Key Laboratory of Gene and Antibody Therapy, Shenzhen International Graduate School, Tsinghua University, Shenzhen, Guangdong, China.

Sophaline B (SPB), extracted from the seeds of L., is a natural bioactive compound that effectively exerts antiviral activities against the hepatitis B virus. This is the first study to demonstrate that SPB exerts anti-tumor effects on NSCLC by inducing pyroptosis and autophagy.

View Article and Find Full Text PDF

The epithelial-to-mesenchymal transition (EMT) is a common feature in early cancer invasion. Increased vimentin is a canonical marker of the EMT; however, the role of vimentin in EMT remains unknown. To clarify this, we induced EMT in lung cancer cells with TGF-β1, followed by treatment with the vimentin-targeting drug ALD-R491, live-cell imaging, and quantitative proteomics.

View Article and Find Full Text PDF

Ovarian cancer (OC) is the second most common female reproductive cancer and the most lethal gynecological malignancy worldwide. Most human OCs are characterized by high rates of drug resistance and metastasis, leading to poor prognosis. Improving the outcomes of patients with relapsed and treatment-resistant OC remains a challenge.

View Article and Find Full Text PDF

Radiotherapy is a powerful tumor therapeutic strategy for gastric cancer patients. However, radioresistance is a major obstacle to kill cancer cells. Ginger ( Roscoe) exerts a potential function in various cancers and is a noble combined therapy to overcome radioresistance in gastric cancer radiotherapy.

View Article and Find Full Text PDF

The Role of Vimentin Peptide Citrullination in the Structure and Dynamics of HLA-DRB1 Rheumatoid Arthritis Risk-Associated Alleles.

Int J Mol Sci

December 2024

Department of Medicine, Division of Clinical Immunology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, SP, Brazil.

Citrullination, a post-translational modification (PTM), plays a critical role in rheumatoid arthritis (RA) by triggering immune responses to citrullinated self-antigens. Some HLA-DRB1 genes encode molecules with the shared epitope (QKRAA/QRRAA) sequence in the peptide-binding groove which preferentially presents citrulline-modified peptides, like vimentin, that intensifies the immune response in RA. In this study, we used computational approaches to evaluate intermolecular interactions between vimentin peptide-ligands (with/without PTM) and HLA-DRB1 alleles associated with a significantly increased risk for RA development.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!